JAH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
JAH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Jarden's Operating Income for the three months ended in Dec. 2015 was $99 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2015 was $508 Mil.
Operating Margin % is calculated as Operating Income divided by its Revenue. Jarden's Operating Income for the three months ended in Dec. 2015 was $99 Mil. Jarden's Revenue for the three months ended in Dec. 2015 was $2,610 Mil. Therefore, Jarden's Operating Margin % for the quarter that ended in Dec. 2015 was 3.80%.
Jarden's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.
Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Jarden's annualized ROC % for the quarter that ended in Dec. 2015 was -0.41%. Jarden's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2015 was 12.87%.
The historical data trend for Jarden's Operating Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jarden Annual Data | |||||||||||||||||||||
Trend | Dec06 | Dec07 | Dec08 | Dec09 | Dec10 | Dec11 | Dec12 | Dec13 | Dec14 | Dec15 | |||||||||||
Operating Income | Get a 7-Day Free Trial | 522.90 | 576.80 | 572.90 | 639.80 | 507.70 |
Jarden Quarterly Data | ||||||||||||||||||||
Mar11 | Jun11 | Sep11 | Dec11 | Mar12 | Jun12 | Sep12 | Dec12 | Mar13 | Jun13 | Sep13 | Dec13 | Mar14 | Jun14 | Sep14 | Dec14 | Mar15 | Jun15 | Sep15 | Dec15 | |
Operating Income | Get a 7-Day Free Trial | 156.40 | -30.80 | 189.60 | 249.70 | 99.20 |
Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.
Operating Income for the trailing twelve months (TTM) ended in Dec. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $508 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jarden (NYSE:JAH) Operating Income Explanation
1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Jarden's annualized ROC % for the quarter that ended in Dec. 2015 is calculated as:
ROC % (Q: Dec. 2015 ) | ||||||
= | NOPAT | / | Average Invested Capital | |||
= | Operating Income * ( 1 - Tax Rate % ) | / | ( (Invested Capital (Q: Sep. 2015 ) | + | Invested Capital (Q: Dec. 2015 )) | / count ) |
= | 396.8 * ( 1 - 111.68% ) | / | ( (10786.6 | + | 11960.6) | / 2 ) |
= | -46.34624 | / | 11373.6 | |||
= | -0.41 % |
where
Invested Capital | (Q: Sep. 2015 ) | |||||||||||
= | Total Assets | - | Accounts Payable & Accrued Expense | - | Excess Cash | |||||||
= | Total Assets | - | Accounts Payable & Accrued Expense | - | ( Cash, Cash Equivalents, Marketable Securities | - | max(0, Total Current Liabilities | - | Total Current Assets | + | Cash, Cash Equivalents, Marketable Securities | )) |
= | 12875.5 | - | 993.4 | - | ( 1095.5 | - | max(0, 2034.6 | - | 5059.9 | + | 1095.5 | )) |
= | 10786.6 |
Invested Capital | (Q: Dec. 2015 ) | |||||||||||
= | Total Assets | - | Accounts Payable & Accrued Expense | - | Excess Cash | |||||||
= | Total Assets | - | Accounts Payable & Accrued Expense | - | ( Cash, Cash Equivalents, Marketable Securities | - | max(0, Total Current Liabilities | - | Total Current Assets | + | Cash, Cash Equivalents, Marketable Securities | )) |
= | 14293.1 | - | 1034.1 | - | ( 1298.4 | - | max(0, 2275.3 | - | 4654.3 | + | 1298.4 | )) |
= | 11960.6 |
Note: The Operating Income data used here is four times the quarterly (Dec. 2015) data.
2. Joel Greenblatt's definition of Return on Capital:
Jarden's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2015 is calculated as:
ROC (Joel Greenblatt) % | (Q: Dec. 2015 ) | ||||||
= | EBIT | / | Average of (Net fixed Assets | + | Net Working Capital) | ||
= | EBIT | / | Average of (Property, Plant and Equipment | + | Net Working Capital) | ||
Q: Sep. 2015 | Q: Dec. 2015 | ||||||
= | EBIT | / | ( ( (Property, Plant and Equipment + Net Working Capital) | + | (Property, Plant and Equipment + Net Working Capital) ) | / | count ) |
= | 396.8 | / | ( ( (942.2 + max(2474.8, 0)) | + | (1074.4 + max(1674.1, 0)) ) | / | 2 ) |
= | 396.8 | / | ( ( 3417 | + | 2748.5 ) | / | 2 ) |
= | 396.8 | / | 3082.75 | ||||
= | 12.87 % |
where Working Capital is:
Working Capital | (Q: Sep. 2015 ) | ||||||||||
= | (Accounts Receivable | + | Total Inventories | + | Other Current Assets) | - | (Accounts Payable & Accrued Expense | + | Defer. Rev. | + | Other Current Liabilities) |
= | (1450 | + | 2084.5 | + | 429.9) | - | (993.4 | + | 0 | + | 496.2) |
= | 2474.8 |
Working Capital | (Q: Dec. 2015 ) | ||||||||||
= | (Accounts Receivable | + | Total Inventories | + | Other Current Assets) | - | (Accounts Payable & Accrued Expense | + | Defer. Rev. | + | Other Current Liabilities) |
= | (1310.4 | + | 1783.2 | + | 262.3) | - | (1034.1 | + | 183.4 | + | 464.3) |
= | 1674.1 |
When net working capital is negative, 0 is used.
Note: The EBIT data used here is four times the quarterly (Dec. 2015) EBIT data.
3. Operating Income is also linked to Operating Margin %:
Jarden's Operating Margin % for the quarter that ended in Dec. 2015 is calculated as:
Operating Margin % | = | Operating Income (Q: Dec. 2015 ) | / | Revenue (Q: Dec. 2015 ) |
= | 99.2 | / | 2610.4 | |
= | 3.80 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.
Be Aware
Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Thank you for viewing the detailed overview of Jarden's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Richard T Sansone | officer: EVP - Operations | ONE CANTERBURY GREEN, 6TH FLOOR STAMFORD CT 06901 |
William P Lauder | director | 767 FIFTH AVENUE, NEW YORK NY 10153 |
Irwin D Simon | director | C/O THE HAIN CELESTIAL GROUP INC., 1111 MARCUS AVENUE, LAKE SUCCESS NY 11042 |
Michael S Gross | director | C/O SOLAR CAPITAL LTD., 500 PARK AVENUE, 3RD FLOOR, NEW YORK NY 10022 |
Robert L Wood | director | C/O DOW CHEMICAL CO, 2030 DOW CENTER, MIDLAND MI 48674 |
John Edward Capps | officer: EVP-Admin, Gen. Counsel & Sec. | 2381 EXECUTIVE CENTER DRIVE, BOCA RATON FL 33431 |
Alan W Lefevre | officer: EVP - Finance & CFO | HERBALIFE NUTRITION, 800 W. OLYMPIC BLVD. SUITE 406, LOS ANGELES CA 90015 |
Martin E Franklin | director, officer: Executive Chairman | C/O MARIPOSA CAPITAL, LLC, 5200 BLUE LAGOON DRIVE, SUITE 855, MIAMI FL 33126 |
Ashken Ian G H | director, officer: Vice Chairman and President | C/O MARIPOSA CAPITAL, LLC, 5200 BLUE LAGOON DRIVE, SUITE 855, MIAMI FL 33126 |
James E Lillie | director, officer: Chief Executive Officer | C/O MOORE CORPORATION LIMITED, ONE CANTERBURY GREEN, STAMFORD CT 06901 |
Richard J Heckmann | director | 75080 FRANK SINATRA DRIVE PALM DESERT CA 92211 |
John David Tolbert | officer: SVP, HR & Corp. Risk | 345 S HIGH STREET, STE 201, MUNCIE IN 47305 |
Patricia Mount | officer: SVP, Finance | JARDEN CORPORATION, 555 THEODORE FREMD AVENUE, RYE NY 10580 |
Rene Pierre Azria | director | C/O JARDEN CORP, 555 THEODORE FREMD AVE, RYE NY 10580 |
Charles R Kaye | director | C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017 |
From GuruFocus
By Holly LaFon • 03-07-2014
By gurufocus 10qk • 08-06-2010
By David Goodloe David Goodloe • 11-27-2015
By gurufocus 10qk • 10-29-2010
By Canadian Value Canadian Value • 05-06-2015
By GuruFocus Research GuruFocus Editor • 02-08-2011
By GuruFocus Research GuruFocus Editor • 12-23-2009
By Myra Ramdenbourg Myra Ramdenbourg • 12-09-2013
By GuruFocus Research GuruFocus Editor • 12-23-2009
By GuruFocus Research GuruFocus Editor • 02-08-2011
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.